» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 1-1 of 1 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
Study aim: Determination of the effect of curcumin-piperine supplementation on disease duration, severity and clinical signs, and inflammatory factors in patients with coronavirus(COVID-19): A randomized, double-blind, placebo-controlled clinical trial study Design: This is a randomized, placebo-controlled, double-blind parallel-group clinical trial. one hundred participants will randomly allocated to receive curcumin-piperine supplement per day (n = 50) or placebo (n = 50). Settings and conduct: In this study, patients with coronavirus will recruited from hospitals of Isfahan University of Medical Sciences. Subjects will stratified according to gender. Random assignment will done by the use of table of random numbers. The enrolling participants, and assigning participants to the groups will carried out by a relevant specialist.The curcumin-piperine supplement and its placebos will be packed in similar boxes, and the researcher and the patients will not be aware of the content of the pack until the end of the study. Participants/Inclusion and exclusion criteria: Inclusion criteria: Tendency to participate in the study; People aged 18-65 years; Diagnosis of Covid-19 based on clinical findings and imaging findings (Chest X Ray), CT scan or PCR Exclusion criteria: Age less than 20 and more than 75 years;Taking warfarin; Sensitivity to plant products such as turmeric and pepper Intervention groups: Individuals will randomly assigned to two groups to receive 1000 mg/day curcumin-piperine supplement or placebo for 12 weeks. Main outcome variables: CT of the chest, body temperature, length of hospital stay, hs-CRP, ESR, ALT, AST, LDH, BUN, creatinine, CBC, blood oxidative stress indices ( SOD, MDA, TAC), Albumin, Severity of the disease, severity and number of coughs
IRCTID: IRCT20121216011763N46
  1. Evaluation of the effect of curcumin-piperine supplementation in patients with coronavirus admitted to the intensive care unit (ICU): a double-blind clinical trial studyCommunity Verified icon
  2. The effect of Curcumin-Piperine supplementation on cardiometabolic factors, hepatic steatosis and fibrosis of fibroscan results and liver function in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial
  3. The effect of curcumin-piperine supplementation on inflammatory and metabolic factors in patients with rheumatoid arthritis: a double-blind clinical trial study
  4. The effects of curcumin plus piperine supplementation on cardiometabolic risk factors and fibroscan findings in patients with non-alcoholic steatohepatitis (NASH): a randomized doubleblind placebo-controlled trial
  5. Evaluation of the effectiveness of curcumin-piperine supplementation on inflammatory factors, cardiac biomarkers, atrial fibrillation and clinical outcomes after coronary artery bypass graft surgery (CABG): A randomized double-blind, placebo-controlled, dose–response pilot study
  6. The effect of chitosan supplementation on clinical symptoms in patients with COVID-19
  7. The effect of propolis supplementation on clinical symptoms in patients with coronavirus (COVID-19): A randomized, double-blind, placebo-controlled clinical trial
  8. Investigating the effect of curcumin-piperine supplementation in accelerating the recovery period of patients with covid-19
  9. The effect of curcumin-piperine supplementation on cardiometabolic, inflammatory and oxidative stress factors and macular vascular density in optical coherence tomography angiography (OCTA) in patients with non-proliferative diabetic retinopathy.
  10. The effects of curcumin-piperine supplementation on inflammatory, oxidative stress and metabolic indicators in patients with ischemic stroke in the rehabilitation phase: a double-blind clinical trial study
Loading...